Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.
The Lancet Oncology.
Times cited: 56
Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer.
Times cited: 38